<?xml version="1.0" encoding="utf-8"?><svg:svg xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:svg="http://www.w3.org/2000/svg" version="1.1" width="595.22px" height="842px" preserveAspectRatio="none" viewBox="0 0 595.22 842"><svg:defs><svg:clipPath id="--clippath0" transform=""><svg:path d="M 0 0 L 595.22 0 L 595.22 842 L 0 842 Z" stroke-miterlimit="0" stroke-linecap="" stroke-linejoin="" stroke-width="1px" stroke-dasharray="" stroke-dashoffset="0px" fill="none" clip-rule="nonzero"></svg:path></svg:clipPath><svg:style type="text/css">@font-face { font-family: "g_d0_f1";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f2";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f3";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f4";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f5";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f6";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f7";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f8";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f9";; src: url(data:font/woff;base64,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); } </svg:style></svg:defs><svg:g transform="matrix(1 0 0 -1 0 842)"><svg:g transform=""><svg:path d="M 0 0 L 595.22 0 L 595.22 842 L 0 842 Z" stroke-miterlimit="0" stroke-linecap="" stroke-linejoin="" stroke-width="1px" stroke-dasharray="" stroke-dashoffset="0px" fill="none" clip-rule="nonzero"></svg:path></svg:g><svg:g clip-path="url(#clippath0)"><svg:g transform=""><svg:text transform="matrix(11 0 0 11 389.531 779.9031) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.258" x="0 0.577 1.063 1.401 2.098 2.584 3.018 3.577 3.747 4.264 4.758 4.964 5.45 5.602 5.952 6.474 6.994 7.308 7.646 7.828 8.262 8.444 8.961 9.483 9.833 10.345 10.695 11.2 11.382 11.904 12.218 12.74 13.054 13.236 13.67" font-family="g_d0_f1" font-size="1px" fill="rgb(43,46,52)">Farmacología, nutrición y dietética</svg:tspan></svg:text><svg:text transform="matrix(7.5 0 0 7.5 536.703 52.9521) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.25" x="0 0.556 1.112" font-family="g_d0_f2" font-size="1px" fill="rgb(43,46,52)">287</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 70.8661 756.8378) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f3" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 76.32 756.8378) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)"> </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 79.3701 756.1358) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.299" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">β</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 84.3093 756.8378) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.722 0.944 1.388 1.832 2.276 2.72 3.164 3.608 3.886 4.33 4.719 4.941" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">-bloqueantes: </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 79.3701 745.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.445 1.889 2.333 2.777 3.166 3.61 4.054 4.276 4.72 4.942 5.164 5.553 5.997 6.441 6.83 7.274 7.941 8.385 8.607 9.051 9.495 9.717 10.161 10.55 10.772 11.216 11.66 12.104 12.548 12.77" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">- Reducen el consumo de oxígeno. </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 79.3701 734.8382) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.501 1.779 2.001 2.223 2.667 3.056 3.278 3.722 4.166 4.388 4.832 5.054 5.498 5.942 6.22 6.498 6.942 7.386 7.775 7.997 8.441 8.885 9.107 9.329 9.607 10.051 10.495 10.939 11.161 11.55 11.994 12.272 12.716 12.938 13.382 13.604 13.993 14.215 14.659 15.103 15.325 15.769 16.047 16.269 16.491 16.88 17.324 17.768 18.212 18.879 19.101 19.49 19.934 20.156 20.6 21.044 21.322 21.711 21.933 22.322 22.6 23.044 23.488 23.766 24.21" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">- Útiles en hipertensión, taquicardia y dolor isquémico persistente.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 79.3701 723.8384) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.9449 1.3889 1.6669 2.1109 2.5549 2.9989 3.4429 3.8869 4.1089 4.5529 4.7749" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">- Propanolol.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 70.8661 701.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f3" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 76.32 701.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.3389 0.8389 1.2829 1.5049 1.8939 2.1159 2.5599 2.7818 3.2258 3.6698 3.9478 4.3918 4.8358 5.2798 5.7238 5.9458 6.3348 6.6128 7.0568 7.4458 7.6678" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)"> Calcio antagonistas: </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 79.3701 690.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278" font-family="g_d0_f3" font-size="1px" fill="rgb(111,113,117)">- </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 87.874 690.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.222 0.889 1.333 1.555 1.999 2.443 2.887 3.0824 3.3044 3.7484 3.9438 4.3878 4.8318 5.1098 5.3878 5.8318 6.2758 6.7198 6.9152 7.3592 7.8032 7.9986 8.3876 8.8316 9.0536 9.4426 9.6646 10.1086 10.304 10.748 10.97 11.1654 11.3874 11.8314 12.1094 12.5534 12.8314 13.0534 13.4974 13.7754 13.9708 14.3598 14.8038 15.0258 15.4698 15.6918 16.1358 16.3438 16.5658 16.7612 17.2052 17.4832 17.9272 18.3162 18.7602 19.1492 19.5932 20.0372 20.2326 20.6216 21.0656 21.4546 21.8986 22.3426 22.5646 22.7866 23.2306 23.5086 23.9526 24.3416 24.5636 25.0076 25.4516 25.647 26.091 26.369 26.647 27.091 27.369 27.591 28.035 28.257 28.4524 28.8414 29.0368 29.4808 29.7028 30.0918 30.7588 30.9808 31.4248 31.8688 32.2578 32.4798 32.9238 33.3678 33.5632 34.0072 34.4512 34.6466 34.8686 35.3126 35.7016 35.897 36.175 36.619 37.008 37.23 37.619 37.897 38.341 38.785 39.174 39.396 39.84 40.229 40.4244 40.8134 41.2574 41.6464 42.0354 42.4794 42.7014 43.1454 43.4234 43.8674" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Impiden la entrada de calcio al interior celular. Provocan vasodilatación arterial y disminución de las resistencias vasculares</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 486.166297 690.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.1954 0.6394 1.0834 1.3614 1.5834 1.8614 2.3054 2.5834 2.8054 3.1944 3.6384 4.0274" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)"> periféricas.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 79.3701 679.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278" font-family="g_d0_f3" font-size="1px" fill="rgb(111,113,117)">- </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 87.874 679.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.463 0.907 1.185 1.629 2.073 2.517 3.184 3.406 3.628 4.072" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Verapamilo.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 70.8661 657.793) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.226" x="0 0.611 1.111 1.389 1.667 2.167 2.445 2.945 3.445 3.778 4.056 4.556 5.056 5.5 5.778 6.222 6.722" font-family="g_d0_f5" font-size="1px" fill="rgb(61,68,70)">Antihipertensivos</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 70.8661 635.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.556 1 1.389 1.611 2.055 2.444 2.833 3.277 3.499 3.943 4.387 4.831 5.22" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Dos escalones:</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 70.8661 613.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f3" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 76.32 613.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)"> </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 79.3701 613.802) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.662 0.879 1.318 1.813 2.03 2.2665" font-family="g_d0_f6" font-size="1px" fill="rgb(43,46,52)">Nivel I</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 102.224701 613.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.222 0.4635 0.9075 1.1295 1.5735 1.8515 2.2955 2.5735 2.7955 3.1845 3.6285 4.0175 4.2395 4.481 4.925 5.147 5.591 6.035 6.479 6.923 7.367 7.811 8.089 8.533 8.922 9.1635 9.6075 10.0515 10.3295 10.7735 11.2175 11.6615 11.9395 12.3835 12.6055 12.9945 13.4385 13.8275 14.0495 14.291 14.735 15.179 15.457 15.901 16.345 16.789 17.233 17.455 17.844 18.122 18.566 18.955 19.1965 19.6405 20.0845 20.3065 20.548 20.937 21.381 21.603 21.992 22.214 22.658 22.88 23.1215 23.3435 23.7875 24.2315 24.4535 24.8975 25.1195 25.5635 26.0075 26.2855 26.7295 27.1185 27.36 27.804 28.248 28.4895 28.7115 29.1555 29.397 29.841 30.285 30.618 30.84 31.507 31.951 32.1925 32.6365 33.0805 33.322 33.711 34.155 34.599 34.988 35.432 35.71 36.099 36.321 36.765 37.209 37.4505 37.8945 38.3385 38.58 38.802 39.246 39.4875 39.9315 40.3755 40.8195 41.0415 41.4855 41.7635 42.2075 42.6515 43.0405 43.2625 43.7065 44.1505 44.392 44.781 45.0225 45.4665" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">: diuréticos, bloqueantes adrenérgicos, antagonistas del calcio, inhibidores de la enzima de conversión de la angiotensina y an</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 515.409309 613.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.722" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">ta-</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 79.369225 602.8382) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.888 1.332 1.554 1.943 2.221 2.665 3.054 3.276 3.72 4.164 4.386 4.608 5.052 5.441 5.663 5.941 6.385 6.774 7.218 7.662 7.94 8.384 8.662 9.106 9.495 9.717 10.161 10.605 10.827 11.271 11.715 12.159 12.381 12.825 13.103 13.547 13.991 14.38 14.602 15.046 15.49 15.712 15.934 16.156 16.378" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">gonistas de los receptores de angiotensina II. </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 70.8661 591.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f3" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 76.32 591.802) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.3389 1.0009 1.2179 1.6569 2.1519 2.3689 2.5858 2.8588" font-family="g_d0_f6" font-size="1px" fill="rgb(43,46,52)"> Nivel II</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 104.506199 591.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.222 0.444 0.888 1.11 1.554 1.998 2.276 2.72 3.164 3.553 3.997 4.275 4.719 5.108 5.33 5.719 6.163 6.607 6.885 7.163 7.607 7.829 8.273 8.662 8.884 9.273 9.495 9.884 10.328 10.717 11.161 11.605 11.827 12.049 12.493 12.771 13.215 13.659 14.103 14.381 14.825 15.214 15.436 15.88 16.324 16.546 16.99 17.434 17.712 17.934 18.212 18.656 18.934 19.156 19.545 19.989 20.378" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">: hipotensores centrales y vasodilatadores de periféricos.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 70.8661 118.7931) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.226" x="0 0.556 1.056 1.556 2.056 2.556 2.834 3.334 3.834 4.112 4.612" font-family="g_d0_f5" font-size="1px" fill="rgb(61,68,70)">Coagulación</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 70.8661 96.838499) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f3" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 76.32 96.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.728 0.95 1.394 1.672 1.894 2.338 2.782 3.004 3.226 3.504 3.726 4.115 4.559 4.948 5.17 5.392 5.836 6.28 6.558 6.78 7.002 7.224 7.668 7.946 8.168 8.612 9.056 9.278 9.5 9.778 10 10.389 10.833 11.222 11.444 11.666 12.11 12.554 12.832 13.054 13.498 13.942 14.22 14.664 15.108 15.552 15.996 16.274 16.718 17.107 17.329 17.773 17.995 18.439 18.883 19.327 19.771 20.049 20.493 20.771 20.993 21.437 21.826 22.048 22.437 22.659 23.103 23.547 23.825 24.047 24.436 24.88 25.324 25.768 26.212 26.434 26.878 27.322 27.6 28.044 28.433" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)"> Fibrinolíticos, antiﬁ brinolíticos, antiagregantes plaquetarios y anticoagulantes.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 70.8661 85.8381) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f3" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 76.32 85.8381) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.728 0.95 1.394 1.672 1.894 2.338 2.782 3.004 3.226 3.504 3.726 4.115 4.559 4.948 5.17 5.392 5.836 6.058 6.336 6.78 7.224 7.446 7.89 8.279 8.723 8.945 9.167 9.445 9.723 10.001 10.405 10.961 11.183 11.405 11.627 12.071 12.46 12.738 13.016 13.46 13.904 14.182 14.626 15.07 15.514 15.736 16.18 16.624 17.013 17.457 17.679 17.901 18.179 18.623 18.901 19.345 19.789 20.011 20.455 20.844 21.288 21.51 21.732 22.176 22.62 22.842 23.231 23.509 23.787 24.231 24.675 24.897 25.341 25.73 26.174 26.396 26.618 27.062 27.34 27.784 28.173 28.395 28.839 29.283 29.672 30.116 30.338 30.727 30.949 31.227 31.671 32.06 32.504 32.948 33.392 33.614 34.058 34.447 34.891 35.113 35.335 35.779 36.39 36.89 37.112 37.334" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)"> Fibrinolíticos: alteplasa (rt-PA), estreptoquinasa, reteplasa, anistreplasa, urokinasa y tecneplasa (TNK). </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 70.8661 74.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f3" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 76.32 74.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.895 1.339 1.783 2.227 2.505 2.727 3.171 3.615 4.004 4.226 4.67 5.114 5.336 5.78 6.224 6.446 6.89 7.112 7.556 8 8.389 8.833 9.055 9.722 10.166 10.388 10.832 11.221 11.665 11.887 12.331 12.539" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)"> Heparinas de bajo peso molecular.</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 92.1108 329.3325) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.556 0.778 1.278 1.722 1.936 2.436 2.936 3.15 3.65 4.15 4.872 5.094 5.594 5.816 6.26 6.538 6.871 7.371 7.871 8.093 8.593" font-family="g_d0_f6" font-size="1px" fill="rgb(43,46,52)">Vías de administración</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 177.4 329.4175) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.212 0.646 0.914 1.182 1.616 1.995 2.429 2.863 3.297 3.676" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Intravenosa</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 92.1108 311.6155) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.611 1.111 1.555 1.777 2.221 2.443 2.943 3.443 3.943 4.165 4.443 4.943 5.443 5.665 6.165" font-family="g_d0_f6" font-size="1px" fill="rgb(43,46,52)">Dosis habituales</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 177.4 311.194) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.606" font-family="g_d0_f3" font-size="1px" fill="rgb(64,198,192)"> </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 184.852 311.3045) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.556 1 1.389 1.611 2 2.222 2.444 2.888 3.11 3.499 3.721 4.165 4.387 4.609 5.053 5.497 5.719 6.163 6.607 6.829 7.496 7.94 8.162 8.384 8.606 9.05 9.494 9.772 10.216 10.438 10.66 10.938 11.382 11.826 12.27 12.548 12.77 13.214 13.658 13.88 14.324 14.768 14.99 15.212 15.656 15.934 16.378 16.656 17.045 17.489 17.711 18.155 18.544 18.766 19.21 19.654 19.876 20.32 20.764 20.986 21.653 21.875 22.319 22.763 23.041 23.485 23.874 24.096 24.54 24.984 25.373 25.651 26.095 26.317 26.761 27.205 27.483 27.927 28.371 28.815 29.093 29.315 29.593 30.037 30.426 30.87 31.314 31.758 32.147 32.425 32.869 33.091 33.313 33.924 34.368 34.59 34.979 35.423 35.867 36.145 36.589 37.033 37.477 37.866 38.31 38.588" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Dosis inicial de 50 mg (lento) repetida en intervalos de 10 minutos hasta obtener respuesta. No sobrepasar </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 185.9043 301.1045) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.222 0.666 1.055 1.277 1.721 2.165 2.609 2.831 3.498 3.942" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">los 200 mg </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 177.4 290.194) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.606" font-family="g_d0_f3" font-size="1px" fill="rgb(64,198,192)"> </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 184.852 290.3045) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.778 1.222 1.666 1.944 2.388 2.832 3.054 3.721 3.943 4.387 4.831 5.109 5.553 5.775 5.997 6.441 6.663 7.107 7.385 7.829 8.051 8.718 9.162 9.495 10.162 10.384" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Mantenimiento: 0,5-2 mg/min</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 92.1108 274.0065) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.278 0.778 1.278 1.5 2 2.5 3 3.222 3.722 4.222 4.722" font-family="g_d0_f6" font-size="1px" fill="rgb(43,46,52)">Indicaciones</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 177.4 274.0925) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 1.111 1.555 1.833 2.277 2.721 3.165 3.554 3.776 4.22 4.609 4.831 5.275 5.497 5.941 6.385 6.663 6.941 7.385 7.829 8.218 8.44 8.829 9.273" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Emergencias hipertensivas</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 92.1108 258.1325) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.611 1.111 1.611 1.833 2.333" font-family="g_d0_f6" font-size="1px" fill="rgb(43,46,52)">Acción</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 177.4 257.4875) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.307" x="0" font-family="g_d0_f7" font-size="1px" fill="rgb(43,46,52)">β</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 181.7248 258.2185) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.722 0.944 1.388 1.832 2.276 2.72 3.164 3.608 3.886 4.33 4.552 4.996 5.44 5.662 6.051 6.495 6.773 7.217 7.439 7.883 8.272 8.716 8.938 9.382 9.771 10.049 10.271 10.66 11.104 11.326 11.715 11.937 12.381 12.603 13.047 13.491 13.935 14.379 14.823 15.267 15.545 15.989 16.211 16.655 17.099 17.321 17.543 17.987 18.376 18.598 18.876 19.32 19.709 20.153 20.597 20.875 21.319 21.597 22.041 22.43 22.652 23.096 23.54 23.818 24.262 24.706 25.15 25.428 25.872 26.094 26.483 26.927 27.316" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">-bloqueante no cardioselectivo y bloqueante de los receptores adrenérgicos </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 415.790149 257.4875) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.307" x="0" font-family="g_d0_f7" font-size="1px" fill="rgb(43,46,52)">α</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 420.243299 258.2185) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.222 0.611" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)"> y </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 427.322949 257.4875) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.307" x="0" font-family="g_d0_f7" font-size="1px" fill="rgb(43,46,52)">β</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 431.647749 258.2185) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.222 0.444 0.888 1.11 1.332 1.776 1.998 2.442 2.886 3.33 3.774 4.218" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">. El bloqueo </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 469.386047 257.4875) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.307" x="0" font-family="g_d0_f7" font-size="1px" fill="rgb(43,46,52)">α</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 473.840047 258.2185) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.222 0.666 0.944 1.388 1.832 2.276 2.665 3.109" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)"> produce </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 177.399985 248.0185) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.389 0.833 1.222 1.666 2.11 2.332 2.554 2.998 3.276 3.72 4.109 4.331 4.775 5.219 5.441 5.663 6.107 6.329 6.718 7.385 7.607 8.051 8.495 8.884 9.106 9.55 9.994 10.216 10.66 11.104 11.326 11.548 11.992 12.214 12.492 12.936 13.325 13.547 13.936 14.214 14.658 15.102 15.491 15.713 16.157 16.379 16.768 17.212 17.601 17.99 18.434 18.656 19.1 19.378 19.6 19.989 20.433 20.877 21.099 21.543 21.987 22.376 22.765 23.209 23.653 24.042 24.486 24.708 25.152 25.596 25.818 26.04 26.484 26.706 27.15 27.428 27.872 28.261 28.483 28.927 29.371 29.593 30.037 30.315 30.593 31.037 31.315 31.537 31.981" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">vasodilatación, disminución de la resistencia vascular con descenso de la presión arterial</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 92.1108 230.6366) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.5 0.778 1.278 1.778 2.056 2.556 3 3.222 3.666 4.166 4.666 5.166 5.666 6.166 6.666 6.999 7.221 7.721" font-family="g_d0_f6" font-size="1px" fill="rgb(43,46,52)">Efectos secundarios</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 177.4 230.7225) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.556 0.778 1.222 1.666 1.944 2.388 2.832 3.221 3.443 3.887 4.331 4.553 4.997 5.275 5.553 5.997 6.275 6.497 6.941 7.163 7.385 7.607 8.051 8.329 8.773 9.217 9.439 9.828 10.272 10.55 10.994 11.216 11.66 11.882 12.104 12.493 12.937 13.326 13.77 14.159 14.603 15.047 15.436 15.714 15.992 16.214 16.603 16.992 17.214 17.658 18.102 18.324 18.768 19.212 19.49 19.712 19.99 20.434 20.712 20.934 21.323 21.767 21.989 22.378 22.822 23.266 23.488 23.932 24.321 24.599 24.877 25.321 25.988 26.21 26.654 27.098 27.542 27.986 28.375 28.597 28.875 29.153 29.375 29.819 30.208 30.43 30.819 31.041 31.485 31.929 32.207 32.874 33.096 33.54 33.984 34.428 34.872 35.261 35.483 35.705 36.149 36.593 37.037 37.426 37.87 38.314 38.703 38.925" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Hipotensión arterial, bradicardia, vasoconstricción periférica con extremidades frías y hormigueos, náuseas, </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 177.4 220.5225) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.389 0.833 1.5 1.722 2 2.444 2.833 3.055 3.277 3.555 3.999 4.443 4.887 5.165 5.387 5.665 6.109 6.498 6.72 7.164 7.386 7.608 7.83 8.219 8.663 8.941 9.385 9.607 10.051 10.495 10.717 10.939 11.606 12.05 12.328 12.772 13.216 13.605 13.827 14.049 14.493 14.771 15.215 15.659 16.048 16.492 16.936 17.325 17.769 18.213 18.602 19.269" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">vómitos, rubor facial, cefalea, mareos, broncoespasmo</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 92.1108 205.6525) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.278 0.778 1.056 1.556 1.889 2.389 2.889 3.389 3.611 4.111 4.611 5.111" font-family="g_d0_f6" font-size="1px" fill="rgb(43,46,52)">Interacciones</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 177.4 205.231) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.606" font-family="g_d0_f3" font-size="1px" fill="rgb(64,198,192)"> </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 184.852 205.3415) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.5 0.722 1.111 1.555 1.833 2.277 2.721 3.165 3.609 3.887 4.331 4.553 4.942 5.386 5.83 6.052 6.441" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Bicarbonato sódico</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 177.4 194.431) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.606" font-family="g_d0_f3" font-size="1px" fill="rgb(64,198,192)"> </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 184.852 194.5415) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.556 1 1.444 1.888 2.11 2.499 2.777 3.221" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Agonistas</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 215.53615 193.8105) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.307" x="0" font-family="g_d0_f8" font-size="1px" fill="rgb(43,46,52)"> </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 217.66115 193.8105) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.307" x="0" font-family="g_d0_f7" font-size="1px" fill="rgb(43,46,52)">β</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 221.98595 194.5415) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.722 1.166 1.444 1.888 2.332 2.776 3.054 3.498 3.72 4.109 4.553 4.942 5.164 5.386 5.775 6.219 6.441 6.885 7.329 7.607 8.051 8.718 9.162 9.384 9.606 9.828 10.106 10.55 10.828 11.272 11.716 11.994 12.438 12.66 12.882 13.326 13.77" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">-adrenérgicos (salbutamol, terbutalina)</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 92.111051 179.7226) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.556 0.889 1.389 1.889 2.389 2.889 3.389 3.611 4.111 4.611 5.111 5.555" font-family="g_d0_f6" font-size="1px" fill="rgb(43,46,52)">Precauciones </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 92.111051 169.522599) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.5 0.944 1.444 1.944 2.444 2.666 3.166 3.388 3.888" font-family="g_d0_f6" font-size="1px" fill="rgb(43,46,52)">especiales</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 177.400055 179.807599) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.389 0.833 1.055 1.277 1.721 1.943 2.332 2.776 3.054 3.498 3.72 4.164 4.553 4.997 5.219 5.441 5.997 6.441 6.885 7.274 7.552 7.996 8.385 8.607 9.051 9.273 9.495 10.051 10.495 10.773 10.995 11.439 11.717 11.995 12.217 12.495 13.162 13.384 13.773 14.217 14.606 14.828 15.217 15.439 15.883 16.272 16.716 16.938 17.16 17.382 17.604 18.16 18.604 18.882 19.326 19.77 20.214 20.658 20.88 21.269 21.547 21.991 22.38 22.602 23.046 23.49 23.712 23.934 24.323 24.767 24.989 25.378 25.6 26.044 26.266 26.488 26.877 27.321 27.599 28.043 28.487 28.931 29.598 29.82 30.042 30.486" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Fallo cardiaco. Anestesia. Antiarrítmicos clase I. Antagonistas del calcio (verapamilo)</svg:tspan></svg:text><svg:text transform="matrix(9.5 0 0 9.5 88.0663 346.078) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.244" x="0 0.631 0.993 1.209 1.757 2.196 2.412 2.951 3.167 3.711 4.09 4.602 5.041 5.379 5.595 6.092 6.636 6.821 7.2 7.412 7.924 8.452 9 9.338 9.85 10.062 10.606" font-family="g_d0_f9" font-size="1px" fill="rgb(64,198,192)">Principio activo: labetalol</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 91.9219 546.8775) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.556 0.778 1.278 1.722 1.936 2.436 2.936 3.15 3.65 4.15 4.872 5.094 5.594 5.816 6.26 6.538 6.871 7.371 7.871 8.093 8.593" font-family="g_d0_f6" font-size="1px" fill="rgb(43,46,52)">Vías de administración</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 177.211 546.9626) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.546 0.814 1.248 1.46 1.672 1.884 2.263 2.697 3.131 3.343 3.555 3.989 4.423 4.857 5.291" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Oral, sublingual</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 91.9219 529.1605) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.611 1.111 1.555 1.777 2.221 2.443 2.943 3.443 3.943 4.165 4.443 4.943 5.443 5.665 6.165" font-family="g_d0_f6" font-size="1px" fill="rgb(43,46,52)">Dosis habituales</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 177.211 529.2465) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.888 1.11 1.777 2.221 2.443 2.832 3.054 3.498 3.72 4.109 4.553 4.997 5.219 5.441 5.885 6.329 6.773 7.217 7.439 7.661 8.05 8.494 8.938 9.382 9.604 10.048 10.492 10.714 11.381 11.603 12.047 12.491 12.769 13.213 13.602 13.824 14.046 14.546 14.99 15.434 15.878 16.156 16.378 16.656 16.878 17.322 17.766 18.155 18.433 18.877 19.099 19.488 19.932 20.154 20.543 20.765 21.154 21.598 21.987 22.431" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">25 mg vía sublingual cada 30 minutos. Repetir hasta seis veces</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 91.9219 512.5315) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.278 0.778 1.278 1.5 2 2.5 3 3.222 3.722 4.222 4.722" font-family="g_d0_f6" font-size="1px" fill="rgb(43,46,52)">Indicaciones</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 177.211 512.6165) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.556 0.778 1.222 1.666 1.944 2.222 2.666 3.11 3.499 3.721 4.165 4.609 4.831 5.275 5.553 5.831 6.275 6.553 6.775 7.219" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Hipertensión arterial</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 91.9219 496.6575) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.611 1.111 1.611 1.833 2.333" font-family="g_d0_f6" font-size="1px" fill="rgb(43,46,52)">Acción</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 177.211 496.7425) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.576 0.818 1.227 1.914 2.156 2.62 3.084 3.493 3.957 4.199 4.441 4.905 5.314 5.556 6.02 6.262 6.671 7.135 7.377 7.841 8.25 8.492 8.956 9.42 9.662 10.126 10.59 11.054 11.296 11.76 12.058 12.522 12.986 13.395 13.637 14.101 14.565 14.807 15.049 15.291 15.533 15.942 16.184 16.648 16.89 17.354 17.818 18.227 18.525 18.989 19.287 19.751 20.215 20.679 20.921 21.163 21.572 22.036 22.5 22.742 22.984 23.448 23.69 24.099 24.563 25.027 25.436 25.678 26.142 26.606 26.848 27.312 27.776 28.074 28.538 28.78 29.078 29.542 30.006 30.47 30.879 31.288 31.53 31.994 32.458 32.7 33.164 33.628 33.87 34.112 34.576 34.965" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Disminuye los niveles de angiotensina II y aldosterona, con la consiguiente reducción de las </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 177.211 486.5425) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.298 0.762 1.171 1.413 1.822 2.12 2.584 3.048 3.457 3.699 4.163 4.572 4.814 5.223 5.687 6.096 6.505 6.969 7.211 7.675 7.973 8.437 8.846 9.088 9.552 10.016 10.314 10.556 10.854 11.318 11.616 11.858 12.267 12.731 13.14 13.382 13.791 14.033 14.497 14.961 15.203 15.445 15.909 16.151 16.449 16.913 17.211 17.675 18.139 18.548 18.79 19.254 19.718 19.96 20.424 20.888 21.13 21.761 22.225 22.467 22.876 23.118" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">resistencias vasculares periféricas y de la retención de Na y H</svg:tspan></svg:text><svg:text transform="matrix(4.9555 0 0 4.9555 378.604 484.494834) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">2</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 380.903 486.5425) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.576 0.818 1.06 1.302 1.766 2.008 2.417 2.881 3.345 3.587 3.829 4.238 4.702 5.166 5.63 6.094 6.503 6.967 7.209 7.673 7.915 8.379 8.843 9.307 9.549 9.847 10.311 10.775 11.239 11.648 12.057 12.299 12.763 13.227 13.469 13.933 14.397 14.639 14.881 15.325" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">O, lo cual conduce a una reducción de la </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 177.210696 476.3425) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.464 0.762 1.226 1.635 1.877 2.341 2.805 3.047 3.511 3.809 4.107 4.571 4.869 5.111 5.575" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">presión arterial</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 91.9219 459.9865) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.5 0.778 1.278 1.778 2.056 2.556 3 3.222 3.666 4.166 4.666 5.166 5.666 6.166 6.666 6.999 7.221 7.721" font-family="g_d0_f6" font-size="1px" fill="rgb(43,46,52)">Efectos secundarios</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 177.211 460.0715) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.5 0.944 1.222 1.666 1.888 2.332 2.776 2.998 3.22 3.609 4.053 4.497 4.775 5.219 5.608 5.83 6.274 6.718 6.94 7.162 7.384 7.828 8.217 8.661 8.883 9.105 9.494 9.716 10.16 10.604 10.993 11.215 11.659 11.881 12.159 12.603 13.047 13.491 13.713 13.935 14.157 14.601 15.045 15.489 15.711 16.155 16.599 17.043 17.487 18.154 18.598 18.82 19.209 19.431 19.875 20.153 20.597 21.041 21.43 21.874 22.318 22.707 23.151 23.595 23.984 24.651 25.095 25.317 25.539 25.983 26.205 26.594 27.038 27.482 27.926 28.148 28.37 28.648 29.092 29.481 29.925 30.147 30.536 30.98 31.424 31.646 32.09 32.368 32.812 33.09 33.312 33.59 34.034 34.256 34.478 34.922 35.144 35.588 36.032 36.31 36.699 37.143 37.365 37.587 38.031 38.698 38.92 39.364 39.586" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Cefalea, confusión, insuﬁ ciencia renal, angioedema y broncoespasmo, disnea, rash con prurito, hipercaliemia, </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 177.211 449.8715) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.666 1.11 1.554 1.832 2.276 2.72 3.109 3.331 3.775 4.219 4.441 4.885 5.163 5.441 5.885 6.274 6.552 6.996 7.274 7.496 7.885 8.329 8.551 8.773 9.217 9.661 10.105 10.383 10.661 11.105 11.549 11.993 12.437 12.659 13.103 13.325 13.714 13.936 14.38 14.824 15.102 15.546 15.99 16.434 16.656 17.1 17.489 17.711 17.989 18.433 18.822 19.044" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">hipotensión ortostática, neutropenia y agranulocitosis</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 91.9219 435.0015) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.278 0.778 1.056 1.556 1.889 2.389 2.889 3.389 3.611 4.111 4.611 5.111" font-family="g_d0_f6" font-size="1px" fill="rgb(43,46,52)">Interacciones</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 177.211 435.0865) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.556 1 1.278 1.5 1.944 2.333 2.555 2.999 3.443 3.832 4.054 4.276 4.72 4.942 5.386 5.664 6.108 6.386 6.608 6.997 7.441 7.83 8.052 8.274 8.663 8.885 9.552 9.996 10.44 10.718 10.94 11.329 11.773 12.44 12.662 13.329 13.773 14.051 14.273 14.662 15.106 15.495 15.717 15.939 16.217 16.661 17.105 17.549 17.827 18.049 18.493 18.882 19.104 19.548 19.992 20.381 20.603 20.825 21.269 21.713 21.991 22.435 22.879 23.323 23.767 23.989 24.378 24.656 25.1 25.489 25.711 26.155 26.599 26.821 27.043 27.432 27.876 28.098 28.487 28.709 29.153 29.375 29.597 30.041 30.263 30.652 31.096 31.54 31.984 32.206 32.428 32.65 33.094 33.316 33.76 34.204 34.593 34.815 35.259" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Antiácidos, diuréticos, simpaticomiméticos, fenotiacinas, antagonistas del calcio, alcohol, digoxina</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 91.921997 417.8179) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.556 0.889 1.389 1.889 2.389 2.889 3.389 3.611 4.111 4.611 5.111 5.555" font-family="g_d0_f6" font-size="1px" fill="rgb(43,46,52)">Precauciones </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 91.921997 407.617899) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.5 0.944 1.444 1.944 2.444 2.666 3.166 3.388 3.888" font-family="g_d0_f6" font-size="1px" fill="rgb(43,46,52)">especiales</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 177.211 417.397) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.606" font-family="g_d0_f3" font-size="1px" fill="rgb(64,198,192)"> </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 184.663 417.5075) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.722 1.166 1.555 1.999 2.443 2.832 3.054 3.498 3.942 4.164 4.608 5.052 5.274 5.718 6.162 6.551 6.773 7.217 7.661 7.939 8.383 8.772 8.994 9.383 9.827 10.271 10.493 10.937 11.159 11.603 12.047 12.436 12.88 13.102 13.546 14.213 14.435 14.879 15.101 15.323 15.545 15.989 16.378 16.822 17.044 17.266 17.655 17.877 18.321 18.765 19.154 19.376 19.82 20.042 20.431 20.875 21.153 21.597 21.819 22.263 22.652 23.096 23.318 23.54 23.984 24.206 24.65 25.094 25.538 25.982 26.26 26.538 26.982 27.649 27.871 28.315 28.537 28.926 29.148 29.592 29.981 30.259 30.703 31.147 31.591 31.98 32.202 32.646 33.09 33.312 33.756 34.2 34.589 35.033 35.255 35.699 35.977 36.421 36.699 37.143 37.532 37.754 38.198 38.642" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Precaución en pacientes con hipovolemia, insuﬁ ciencia cardiaca, hiponatremia y estados de deshidratación </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 185.7153 407.3075) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.666 1.11 1.554 1.776 2.054 2.332 2.776 3.054 3.498 4.165 4.387 4.831 5.275 5.553 5.997 6.219 6.608 7.052 7.496 7.718 8.162 8.384 8.828 9.106 9.55 9.828 10.05 10.439 10.883 11.272 11.494 11.716 12.16 12.604 13.048 13.492 13.936 14.158 14.547 14.991 15.435 15.824 16.268 16.546 16.768 17.212 17.434 17.878 18.322 18.6 19.044 19.488 19.877 20.099 20.543 20.987 21.209 21.653 21.931 22.209 22.653 22.931 23.153 23.597" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">o en tratamiento con diuréticos, puede causar hipotensión arterial</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 177.211 396.397) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.606" font-family="g_d0_f3" font-size="1px" fill="rgb(64,198,192)"> </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 184.663 396.5075) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.5 0.944 1.388 1.666 1.944 2.388 2.61 2.832 3.276 3.72 3.942 4.164 4.608 4.83 5.108 5.552 5.996 6.385 6.607 7.051 7.495 7.717 8.161 8.439 8.717 9.161 9.439 9.661 10.105" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Control de la tensión arterial</svg:tspan></svg:text><svg:text transform="matrix(9.5 0 0 9.5 88.0952 564.334) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.244" x="0 0.631 0.993 1.209 1.757 2.196 2.412 2.951 3.167 3.711 4.09 4.602 5.041 5.379 5.595 6.092 6.636 6.821 7.2 7.639 8.151 8.69 9.028 9.572 10.111 10.473 10.689" font-family="g_d0_f9" font-size="1px" fill="rgb(64,198,192)">Principio activo: captopril</svg:tspan></svg:text></svg:g></svg:g></svg:g></svg:svg>